Oruka Therapeutics, Inc. (ORKA) Operating cash flow 2016–2025
Oruka Therapeutics, Inc. (ORKA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$88.2MFY2025 · since FY2016: -$15.0M → -$88.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$88.2M | — |
| FY2023 | -$5.0M | +54.1% |
| FY2022 | -$10.9M | +41.8% |
| FY2021 | -$18.8M | -142.9% |
| FY2020 | -$7.7M | -60.9% |
| FY2019 | -$4.8M | +41.8% |
| FY2018 | -$8.2M | +52.8% |
| FY2017 | -$17.5M | -16.6% |
| FY2016 | -$15.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ORKA financial trends
ORKA RevenueORKA Net incomeORKA Net marginORKA Gross profitORKA Gross marginORKA Operating incomeORKA Operating marginORKA Free cash flowORKA Capital expendituresORKA Return on equityORKA Stock buybacksORKA Dividends paidORKA Total assetsORKA Total liabilitiesORKA Shareholders’ equityORKA overview →